Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.50
Bid: 230.50
Ask: 232.00
Change: -6.00 (-2.53%)
Spread: 1.50 (0.651%)
Open: 230.00
High: 238.00
Low: 230.00
Prev. Close: 237.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Bunzl profit up; Rio Tinto sells copper project stake

Tue, 29th Aug 2023 07:49

(Alliance News) - Stocks in London are called to open higher on Tuesday, following a long bank holiday weekend.

In early economic news, UK shop price inflation decelerated further in August, data showed on Tuesday, presenting some "better news for consumers".

According to the latest British Retail Consortium-NielsenIQ tracker, the annual shop price inflation rate cooled to 6.9% in August from 8.4% in July. This was below the three-month average of 8.0% and the lowest rate since October 2022.

Food inflation slowed to 11.5% in August from 13.4% in July, while non-food inflation remained at 4.7%.

In UK company news, Bunzl reported higher interim revenue and profit. Meanwhile, Rio Tinto is selling its majority stake in a large copper project in Peru.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 28.2 points, 0.4%, at 7,366.78

----------

Hang Seng: up 1.9% at 18,475.63

Nikkei 225: closed up 0.2% at 32,226.97

S&P/ASX 200: closed up 0.7% at 7,210.50

----------

DJIA: closed up 213.08 points, or 0.6%, at 34,559.98

S&P 500: closed up 27.60 points, 0.6%, at 4,433.31

Nasdaq Composite: closed up 114.48 points, or 0.8%, at 13,705.13

----------

EUR: up at USD1.0817 (USD1.0783)

GBP: up at USD1.2627 (USD1.2571)

USD: up at JPY146.42 (JPY146.27)

Gold: up at USD1,923.55 per ounce (USD1,906.88)

(Brent): up at USD83.64 a barrel (USD83.57)

(changes since previous London equities close)

----------

ECONOMICS

----------

Tuesday's key economic events still to come:

09:00 CEST Spain retail sales

08:55 EDT US Johnson Redbook retail sales index

09:00 EDT US house price index

10:00 EDT US consumer confidence index

10:00 EDT US labor turnover survey

16:30 EDT US API weekly statistical bulletin

----------

Travel disruption could last for days after flights were cancelled leaving thousands of passengers stranded following an air traffic control technical fault. Holidaymakers were hit by bank holiday travel delays, which started on Monday after a UK air traffic control failure meant flight plans had to be input manually by controllers. By Monday afternoon, 232 flights departing UK airports had been cancelled and 271 arriving flights, according to aviation analytics firm Cirium. This equates to about 8% of all expected departures and 9% of expected arrivals, Cirium added. National Air Traffic Services, the country's leading provider of air traffic control, said at 3.15pm that it had "identified and remedied" the technical issue affecting its systems and it was working with airlines and airports to support affected flights.

----------

BROKER RATING CHANGES

----------

UBS cuts HSBC to 'neutral' (buy) - price target 615 (710) pence

----------

Barclays raises Bluefield Solar Income Fund to 'overweight' (equal weight) - price target 132 (147) pence

----------

Barclays raises Britvic to 'overweight' (equal weight) - price target 1,100 (1,000) pence

----------

COMPANIES - FTSE 100

----------

Bunzl reported revenue of GBP5.91 billion in the six months ended June 30, up 4.5% from GBP5.65 billion a year earlier. The London-based distribution services company's pretax profit increased by 6.9% to GBP317.1 million from GBP296.6 million. The company upped its interim dividend by 5.2% to 18.2p from 17.3p. Also, Bunzl said it has signed an agreement to acquire a business in Poland, and also acquired a business in the Netherlands. The acquisition in Poland is the company's first in the country and, upon completion, will increase the number of countries that Bunzl operates in to 32. In July, Bunzl signed an agreement to acquire Safety First, one of the largest distributors of Personal Protective Equipment products in Poland to a range of end markets. Also in July, Bunzl acquired EcoTools, a Netherlands based specialist online distributor of tool accessories and industrial consumables to customers across the Benelux region.

----------

Rio Tinto and First Quantum Minerals have completed a joint venture deal for La Granja project in Peru. Rio Tinto said La Granja is one of the largest undeveloped copper deposits in the world. First Quantum has acquired a 55% stake in the project for USD105 million. It will invest up to a further USD546 million into the joint venture to sole fund capital and operational costs to take the project through a feasibility study and toward development. Rio Tinto acquired the La Granja Project from the Government of Peru in 2006 and carried out an extensive drilling programme that significantly expanded the declared resource and understanding of the orebody, and established partnerships with host communities, local and national governments.

----------

Standard Chartered on Monday said it has struck a deal to sell its aviation finance leasing business to the Public Investment Fund, Saudi Arabia's sovereign wealth fund. PIF-owned AviLease will buy the StanChart unit for USD700 million, StanChart explained. The lender had said in January that it was exploring its options for the business. AviLease will also fund the repayment of roughly USD2.9 billion worth of net intra-group financing from StanChart, the FTSE 100 constituent said. It added: "On completion of the transaction, Standard Chartered will record an estimated gain of approximately USD300 million and an increase in common equity tier 1 capital ratio by around 19 basis points. Standard Chartered expects to include the net proceeds from the transaction within the overall management of the capital and liquidity position of Standard Chartered and its subsidiaries."

----------

COMPANIES - FTSE 250

----------

PureTech Health reported revenue of USD3.2 million in the first half of 2023, down from USD7.0 million a year earlier. The US-based biotherapeutics company's pretax loss however narrowed to USD13.7 million from USD56.0 million. Founder & Chief Executive Officer Daphne Zohar, said: "The first half of 2023 has been a strong period across both our Founded Entities and Wholly Owned Pipeline. We have achieved important clinical and financial milestones, while executing on our mission of giving life to new classes of medicine to change the lives of patients with devastating diseases."

----------

IG Group said that its Chief Executive Officer June Felix has stepped down, due to "her health situation". The London-based, contracts-for-difference trading platform said she will step down as CEO immediately and leave the company on September 29. The board has appointed Russell Reynolds to undertake a comprehensive search process and expects to appoint a permanent CEO in the coming months. In the meantime, Charlie Rozes will continue in his current role as acting CEO and chief financial officer. Chair Mike McTighe said: "We thank her for the significant contribution she has made over the past eight years as a board member and especially as Group CEO for almost five years. During her tenure as CEO, the company has successfully pursued a strategy to diversify the business while at the same time strengthening its core OTC business resulting in a doubling of the Group's revenue and profit over the period."

----------

OTHER COMPANIES

----------

Workers at two of Chevron's major natural gas plants in Australia are set to go on strike next week, the US energy giant said Tuesday, threatening up to 5% of global LNG supplies. Chevron has been told the strikes will start September 7 at its Gorgon and Wheatstone facilities in Western Australia, an announcement that has spooked markets already upended by Russia's invasion of Ukraine. The company said it would "continue to take steps to maintain safe and reliable operations in the event of disruption at our facilities". "We will also continue to work through the bargaining process as we seek outcomes that are in the interests of both employees and the company," it told AFP in a statement. The Offshore Alliance, which represents Chevron's highly unionised workforce, said the strikes would "escalate each week until Chevron agrees to our bargaining claims" and that the company's efforts to date had been "inept and incompetent".

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more
11 Jul 2022 19:15

TRADING UPDATES: BlueRock hit by extreme weather; Harbour drills well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2022 21:50

IN BRIEF: PureTech Health begins pulmonary fibrosis study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Begins late-stage clinical study of its wholly-owned candidate LYT-100, or deupirfenidone, in idiopathic pulmonary fibrosis. Will evaluate efficacy of two doses, as well as relative tolerability and efficacy with pirfenidone. IPF is a chronic condition causing progressive scarring of the lungs, which currently has a poor prognosis. Also advances LYT-200 programme through clinical development, and plans to begin leukemia study by the end of 2022.

Read more
28 Jun 2022 14:45

IN BRIEF: PureTech Health's founded firm Vedanta launches new facility

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Announces that its founded firm Entity Vedanta Biosciences Inc launches a new manufacturing facility. The facility will "provide clinical and commercial supply of oral therapies" for people infected with a diarrhoea-causing bacteria, firm says.

Read more
21 Jun 2022 14:24

IN BRIEF: PureTech Health's Gelesis wins USD15 million Plenity order

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another USD15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to USD55 million, out of which USD45 million was ordered in the last 12 months, PureTech Health adds.

Read more
14 Jun 2022 16:54

IN BRIEF: PureTech achieves availability milestone for LYT-300 study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Announces results from phase two study of LYT-100-COV on patients with post acute or long Covid with respiratory complications.

Read more
14 Jun 2022 07:33

PureTech reports 'Glyph' milestone, disappointing long Covid results

(Sharecast News) - PureTech Health said on Tuesday that it had met a milestone in proving its 'Glyph' therapeutic platform, while separately announcing disappointing results from a study into long Covid.

Read more
1 Jun 2022 18:21

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review.

Read more
25 May 2022 10:18

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday.

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 11:18

IN BRIEF: PureTech shares rise as unveils USD50 million share buyback

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Approves share buyback of up to USD50 million. Programme follows "follows consultation with shareholders and is consistent with PureTech's capital allocation strategy and stated approach to drive additional value for its shareholders," company says. PureTech says it had USD413.2 million of net cash and cash equivalents at March 31. Given size of balance sheet, PureTech is confident it can return capital to shareholders and also maintain "sufficient cash on hand to deliver" on strategic priorities.

Read more
5 May 2022 10:09

PureTech to buy back up to $50m of shares

(Sharecast News) - PureTech Health has announced a $50m share buyback programme, sending shares in the FTSE 250 biotech sharply higher.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.